MedWell Ai, Inc. (OTCQB: MWAI) has filed its Form 10-Q for the quarter ended December 31, 2025, revealing substantial financial improvements across multiple metrics. The company reported revenue of $548,315 for the fiscal second quarter, representing growth of more than 280% compared to $142,861 in the same period the previous year. For the six-month period, revenue reached $1,075,806, marking an increase of over 700% year-over-year.
Beyond revenue growth, MedWell Ai demonstrated progress in financial management with reduced operating losses and lower general and administrative expenses for both the three- and six-month periods. The company also reported improved net loss per share figures for these periods. Additionally, MedWell Ai reduced its liabilities to $468,655 from $805,500 as of June 30, 2025, indicating stronger financial positioning.
These financial results reflect the company's ongoing implementation of its AI-driven pharmaceutical, healthcare and wellness portfolio strategy. MedWell Ai operates through three primary business units: MedWell USA, LLC, which serves as a B2B distribution and e-commerce ordering portal for pharmaceutical products targeting medical offices, wellness clinics, gyms and online telemedicine companies; MedWell Direct, LLC DBA TeleMD.Ai, which develops and operates B2B/B2C telemedicine platforms connecting consumers, corporations and employees with licensed healthcare providers; and MedWell Facilities, LLC, which focuses on developing and managing real estate opportunities for health and wellness tenants while also creating an AI-driven software platform designed to optimize operations for various healthcare clinics through a licensing model.
The company maintains a corporate website at https://www.medwellai.com and an e-commerce portal at https://www.medwellusa.com for its B2B product ordering services. The financial disclosure was distributed through AINewsWire, a specialized communications platform focused on artificial intelligence advancements that is part of the Dynamic Brand Portfolio at IBN, which provides various corporate communications solutions including wire distribution, editorial syndication, press release enhancement, and social media distribution.
For investors and industry observers, MedWell Ai's financial performance suggests the company's multi-faceted approach to integrating artificial intelligence across healthcare distribution, telemedicine, and clinic management may be gaining traction. The substantial revenue growth, particularly the 700% increase over six months, indicates potential market acceptance of the company's offerings. The simultaneous reduction in operating losses and liabilities suggests improved financial discipline alongside revenue expansion, which could position the company more favorably for future growth initiatives or partnerships within the competitive healthcare technology sector.
The broader implications of these results extend to the healthcare industry's ongoing digital transformation, where AI integration across various service delivery models continues to accelerate. MedWell Ai's performance may signal growing demand for AI-enhanced solutions in pharmaceutical distribution, telemedicine platforms, and clinic management systems. As healthcare organizations increasingly seek efficiency improvements and enhanced patient experiences, companies developing integrated AI solutions across multiple healthcare verticals could see continued market opportunities.
